Food and Drug Administration

4738 Stories, most recent news story added 3 minutes ago

Kalbitor Approved for Hereditary Angiodema

HealthDay - Thu Dec 3, 12:02 pm ET

THURSDAY, Dec. 3 (HealthDay News) -- Kalbitor (ecallantide) has been approved by the U.S. Food and Drug Administration to treat dangerous flares of sudden fluid buildup in people with hereditary angiodema (HAE), the agency said.